Home | QA/EH&S | QA

QA

Quality System

Based on the ICH Guideline Q7, SK’s quality system covers the entire manufacturing process from raw material purchasing, warehousing, production, quality control, to delivery of products. GMP compliance is assured to supply high quality pharmaceutical intermediate and API.

Since 1998 SK’s manufacturing facility and quality system has been audited more than 20 times from major pharmaceutical companies. Our proven reliability of providing high quality pharmaceutical intermediate and API has allowed us continual supply of our quality product to major pharmaceutical companies. Included among them are top 10 global pharmaceutical companies.

SK continues to improve its quality system and facilities to meet customer’s increasing expectation and requirement for pharmaceutical intermediates and commercial API manufacturing.


Quality Policy

Our policy is to make regulatory compliant material for customers to meet their need. This will allow us to be successful and grow our business. We manufacture products to meet quality requirements, regulatory requirements and delivery timeline for our customers.

SK implemented ICH guidelines for research, development, scale-up, pilot and commercial production, testing and release of product as well as other operations. To fulfill our commitment, Compliance with cGMP guideline throughout manufacturing activities, we train personnel with expertise in problem resolution.

Through the quality system management, we continue to provide good quality product with reasonable cost in a timely fashion.


Quality System & Validation System

SK's quality system is composed of 6 subsystems.

Quality System
Laboratory System
Production System
Material System
Facility & Equipment System
Packaging & Labeling System

To verify compliance with SK’s quality principles and to improve our quality system, scheduled regular training and internal audits are performed.

Stringent quality control is enforced to prevent cross contamination from production to release of the product. In the event of a quality issue, we provide prompt attention to investigate for root cause, establish a corrective and preventive action plan in the interests of the customer.


The following is a brief explanation of SK's quality system:


Training Program
Job Description & Responsibility
Job Training Requirement, Scheduled & Repetitive Training by Personal Annual Plan
Training Record with Evaluation
Audit Program
Regular Internal Audit : Once/Year According to Annual Audit Plan
Supplier Audit for Critical Raw Material and Contract Manufacture Control
Customer Audit : by Major Pharma Companies, Approved Supplier for API
Documentation Control System
Issued, Reviewed, Approved, Distributed, Archived, and Destructed by QA
Traceable Numbering System & Documentation
Retention Period Control
Standard Operating Procedures (SOP) System
SOP & Annual Review Program
Change Control System
Change Control Request for Any Change With Possible Impact on Product Quality
Change Control Committee for Approval, Reject, Investigation of the Proposed Change
Non-Conforming Material Control System
Out-Of-Specification(OOS); Investigation, Corrective and Preventive Actions
Deviation : Investigation and CAPA
MRB (Material Review Board) Program : Reprocessing, Rework, Return, Scrap
Determination of Material Disposition for Non-Confirming Material
Separate Rework & Reprocess Program
CAPA (Corrective and Preventive actions)
Area of Concern From Non-Conformance, Complaint, Audit, Etc.
Investigation, Corrective and Preventive Action and Effectiveness Evaluation
Complaint Program
Investigation, Corrective and Preventive Action
Response to Customer
Recall Program
Vendor Qualification
Supplier Control for Raw Material as 4 Staged Status & Supplier History
Sample Qualification by QC Test & Use Test
Qualification Based on Rating of Supplier Questionnaire, On-Site and Postal-Audit, Quality Agreement
Material Control System
Receiving & Inventory Control
Status and Storage Control
Release Approval by Quality Unit
Shipping Control
Pest Control
Production & In-Process Control System
Technical Transfer From R&D to Commercial Site
Production by Master Batch Record
Campaign Review
Annual Product Quality Review
Equipment Cleaning Program
Cleaning Procedure & Records
Maximum Allowable Carryover Control
Calibration and Preventive Maintenance Program
Laboratory Control System
Equipment : Qualification, Calibration and Maintenance
Sampling
Retention Sample Control
Reference Standard and Reagent Control
ID and Specification for Material, Label and Packing Material
Investigation Program for OOS & Deviation
Documentation for Approved Specification & Analytical Test Method
Testing & Result Report: Notebook, QC Result Report, CoA
Stability Test Based on ICH Q1
Analytical Method Validation Based on ICH Q2
Micro Test for Purified Water and Environmental Monitoring

The Validation System is as Follows:


Equipment Qualification
Quality Risk Assessment
URS, FS&DS, DQ, IQ, OQ and PQ
Computerized System Validation
Analytical Method Validation
Method Development, Qualification and Validation
Preparation of Routine Test Method with System Suitability Criteria
Cleaning Validation
Product Grouping for Worst Case Selection, Equipment Grouping
ARL(Acceptable Residue Limit) for Swab/Rinse Limit
3 Successful Campaign and Annual Evaluation for Effectiveness
Preparation of Cleaning Procedure for Each Equipment
Process Validation
Risk Assessment : Critical & Key Process Parameter
Production of 3 Consecutive Validation Batches
Preparation of Master Batch Record for Commercial Production

Regulatory & Customer Audit

Since year 1998, SK has been audited more than 20 times mainly by global major pharmaceutical companies and approved as suitable supplier for pharmaceutical intermediate to commercial API.

FDA and EMEA inspections are expected in the 1st half and the 2nd half of 2011 respectively.


Regulatory Filing Support

SK has supported preparation of chemistry, manufacturing and control (CMC) section for number of Drug Master Files and Investigational New Drug Applications for pharmaceutical intermediates and clinical APIs.

QA/EH&S

  • QA
  • EH&S
    • EH&S Policy
    • EH&S System
    • EH&S Activties
    • EH&S Facilities